It appears to be a subgroup of IDH1 mutated astrocytomas harboring 19q loss and TP53 mutation, which can present morphology similar to oligodendroglial tumors, and also show significantly better prognosis compared to other astrocytomas with IDH mutation (Otani et al., 2018). Here, IDH1 is linked to astrocytoma (excluding glioblastoma).